利用生物标志物患者急性心血管疾病演示幻灯片.pptVIP

Use of Biomarkers in Patients with Acute Cardiovascular Disease;CP1051812-1;ECG Risk Factors in Patients with ACS;Relationship of ECG Changes and FPA*;Long-Term Prognostic Value of ElevatedcTnI in Unstable Angina;Antman, 1998 1.1 (0.4-3.5) Benamer, 1998 13.7 (3.9-48.3) Brisisc, 1998 8.0 (0.9-65.1) Cin, 1996 17.9 (5.2-61.2) Galvani, 1997 6.6 (1.3-32.3) Hamm, 1992 11.7 (3.2-42.6) Luscher, 1997 2.5 (1.3-4.8) Ohman, 1996 4.7 (1.7-12.7) Olatidoye, 1998 156.1 (17.4-1,402) Ottani, 1997 6.6 (2.0-22.1) Rebuzzi, 1998 25.3 (5.2-123.2) Solymoss, 1997 2.4 (0.7-8.1) Stubbs, 1996 1.5 (0.5-4.2) Wu, 1995 31.5 (6.7-144.9) Antman, 1996 3.8 (1.8-8.03);Antman, 1996 3.82 (1.03-14.18) Benamer, 1998 13.68 (3.87-48.33) Brisisc, 1998 7.96 (0.97-65.25) Cin, 1996 17.91 (5.24-61.25) Galvani, 1997 6.55 (1.32-32.38) Hamm, 1992 11.71 (3.22-42.57) Luscher, 1997 5.93 (1.61-21.79) Olatidoye, 1998 156.17 (17.39-1,402.09) Rebuzzi, 1998 25.27 (5.18-123.23) Solymoss, 1997 4.93 (0.72-33.19) Wu, 1995 31.52 (6.89-144.19);cTnI in Patients with Unstable Angina;Synergism of ECG and Elevated Troponins (PARAGON);FRISC-II – GUSTO IV (Death and MI);MyeloperoxidasePredictions of Events When cTNT “Negative”;Prognostic Effects of MPO at 72 Hours;cTnI Negative ACS?;Sensitivity of cTnI, CK-MB, and Myoglobin with Sensitive Contemporary Assays;cTnT and Angiographic Measures;JACC 36(3):970-1062, 2000;LMW Heparin vs VF Heparin in TIMI 11B;TACTICS (TIMI 18);Relation Between Creatinine Clearance,Troponin T, and Outcomes;CURERates and Relative Risks of First Primary Outcome;CP1189452-4;Common 17-amino acidring structure Ring structure highlyconserved 11/17 amino acidsare homologous Ring structure essentialfor physiological activity;Cardiomyocyte;CP1189452-20;AHJ 149(4), April 2005;38 ± 4;BNP Levels in Heart Failure;CP1189452-27;n=1,586; ?50% CHF; 56% male;64±17 yo; 41% COPD; ?30% Hx CHF;AJC 95, April 15, 2005;McCullough PA et al for the BNP Multinational Study Investigators: J Am Coll Cardiol 41:278A, 2003;CP1